Related Experiment Video
Updated: Jun 23, 2026

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
Deadly developments: smoking cessation medicines accessed by Aboriginal and Torres Strait Islander peoples in
Daniel Odo1, Christina Heris1, Raymond Lovett1
1National Centre for Aboriginal and Torres Strait Islander Wellbeing Research, National Centre for Epidemiology and Population Health, The Australian National University, Canberra, ACT, Australia.
Objectives And Importance Of The Study:
The aims of this study were to examine trends in the annual rate of smoking cessation medicines (SCMs) supplied to Aboriginal and Torres Strait Islander people who smoke using dispensings by Services Australia from 2006 to 2019, and to assess whether the provision of SCMs varies between regions supported by a Tackling Indigenous Smoking (TIS) program and those without TIS funding.
Study Type:
Cross-sectional study; analysis of administrative data.
Methods:
Pharmaceutical Benefits Scheme (PBS) and Section 100 Remote Area Aboriginal Health Services (RAAHS) claims data for SCMs supplied to Aboriginal and Torres Strait Islander peoples were analysed. Annual rates of claims per 100 Aboriginal and Torres Strait Islander persons who smoke were calculated. The change in rate of dispensing between 2006 and 2019 was assessed using linear regression, and the patterns in the number of dispensings in TIS and non-TIS areas were described over time.
Results:
From 2006 to 2019, 470,408 and 7413 SCMs were dispensed under the PBS and under the RAAHS program, respectively. Overall, the rate of dispensings per 100 Aboriginal and Torres Strait Islander persons who smoke increased from 1.24 in 2006 to 18.08 in 2019 for PBS (P < 0.001), and from 0.30 in 2006 to 1.70 in 2019 for RAAHS (P < 0.001). From PBS data, the Australian Capital Territory dispensed SCMs at the highest rate (1.50 in 2006 to 27.38 in 2019), and the Northern Territory the lowest (0.23 in 2006 to 3.41 in 2019). Overall, a greater number of dispensings were observed in TIS-funded areas, with 83% of PBS dispensings occurring in these areas. However, rates could not be calculated for TIS and non-TIS comparisons due to limited denominator data.
Conclusions:
Uptake of SCM by Aboriginal and Torres Strait Islander people who smoke increased significantly between 2006 and 2019 (1.24-18.08 for PBS and from 0.30 to 1.70 for RAAHS per 100 people), with a greater number of dispensings observed in areas serviced by a TIS team. Access to medicines to support quitting attempts is an important component of comprehensive tobacco control and may assist people to successfully quit.
More Related Videos
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
06:39Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
Published on: August 28, 2017
Related Concept Videos
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Inhaled Medications
Drug Dependence